| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL EPIDEMIOLOGY |




Departments of * Cancer Research and Molecular Medicine and
Community Medicine and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, and
Department of Medicine, Division of Nephrology, St. Olav University Hospital, Trondheim, Norway; and
Department of Medicine, Division of Nephrology, Ruperto Carola University Heidelberg, Heidelberg, and || Dialysis Center Bad Aibling, Bad Aibling, and Department of Internal Medicine II, University of Regensburg, Regensburg, Germany
Correspondence: Dr. Stein I. Hallan, Department of Medicine, St. Olav University Hospital, N-7006 Trondheim, Norway. Phone: 0047-7386-7273; Fax: 0047-7386-9390; E-mail: stein.hallan{at}ntnu.no
Received for publication July 15, 2008. Accepted for publication November 24, 2008.
Despite the high prevalence of chronic kidney disease (CKD), relatively few individuals with CKD progress to ESRD. A better understanding of the risk factors for progression could improve the classification system of CKD and strategies for screening. We analyzed data from 65,589 adults who participated in the Nord-Trøndelag Health (HUNT 2) Study (1995 to 1997) and found 124 patients who progressed to ESRD after 10.3 yr of follow-up. In multivariable survival analysis, estimated GFR (eGFR) and albuminuria were independently and strongly associated with progression to ESRD: Hazard ratios for eGFR 45 to 59, 30 to 44, and 15 to 29 ml/min per 1.73 m2 were 6.7, 18.8, and 65.7, respectively (P < 0.001 for all), and for micro- and macroalbuminuria were 13.0 and 47.2 (P < 0.001 for both). Hypertension, diabetes, male gender, smoking, depression, obesity, cardiovascular disease, dyslipidemia, physical activity and education did not add predictive information. Time-dependent receiver operating characteristic analyses showed that considering both the urinary albumin/creatinine ratio and eGFR substantially improved diagnostic accuracy. Referral based on current stages 3 to 4 CKD (eGFR 15 to 59 ml/min per 1.73 m2) would include 4.7% of the general population and identify 69.4% of all individuals progressing to ESRD. Referral based on our classification system would include 1.4% of the general population without losing predictive power (i.e., it would detect 65.6% of all individuals progressing to ESRD). In conclusion, all levels of reduced eGFR should be complemented by quantification of urinary albumin to predict optimally progression to ESRD.
Related Articles
J. Am. Soc. Nephrol. 2009 20: 929-930.
J. Am. Soc. Nephrol. 2009 20: A14.
J. Am. Soc. Nephrol. 2009 20: 929-930.
This article has been cited by other articles:
![]() |
G. Jain, R. C. Campbell, and D. G. Warnock Mineralocorticoid Receptor Blockers and Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., October 1, 2009; 4(10): 1685 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Waikar and W. C. Winkelmayer Chronic on Acute Renal Failure: Long-term Implications of Severe Acute Kidney Injury JAMA, September 16, 2009; 302(11): 1227 - 1229. [Full Text] [PDF] |
||||
![]() |
J. Munkhaugen, S. Lydersen, P. R. Romundstad, T.-E. Wideroe, B. E. Vikse, and S. Hallan Kidney function and future risk for adverse pregnancy outcomes: a population-based study from HUNT II, Norway Nephrol. Dial. Transplant., July 3, 2009; (2009) gfp320v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Ikizler CKD Classification: Time to Move Beyond KDOQI J. Am. Soc. Nephrol., May 1, 2009; 20(5): 929 - 930. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673